Skip to main content
. 2009 Feb;10(1):29–39. doi: 10.1089/sur.2007.041

Table 6.

Patient Characteristics and Odds Ratios (85% Confidence Intervals) of Finding that Characteristic among Patients with Specific Resistant Pathogens Compared with Intra-Abdominal Infections with No Resistant Pathogens

  Non-fermenting gram negative1(N = 35) Resistant staphylococci2(N = 74) All enterococci3(N = 161) VRE4(N = 39) Fungi5(N = 267)
Demographics
 Male 1.73
(0.84, 3.59)
1.23
(0.75, 2.01)
0.88
(0.62, 1.24)
0.75
(0.40, 1.44)
0.90
(0.68, 1.20)
 Age 50.7 ± 3.38 50.0 ± 1.58 55.1 ± 1.22 50.5 ± 2.31 54.2 ± 0.92
 APACHE II score6 15.9 ± 1.5 13.2 ± 0.9 15.0 ± 0.6 16.7 ± 1.0 14.7 ± 0.5
 Healthcare-associated 1.59
(0.76, 3.29)
1.83
(1.08, 3.11)
3.16
(2.09, 4.78)
6.35
(2.24, 18.09)
2.40
(1.74, 3.32)
 In intensive care unit 2.80
(1.22, 6.41)
2.40
(1.29, 4.47)
3.11
(1.91, 5.05)
4.72
(2.31, 9.62)
1.86
(1.23, 2.81)
 Days from admission to treatment 13.0 ± 3.4 8.4 ± 2.3 11.9 ± 1.5 23.3 ± 4.1 7.1 ± 0.9
 Maximum temperature, °C 38.2 ± 0.2 38.0 ± 0.1 37.9 ± 0.1 37.9 ± 0.2 37.9 ± 0.1
 Maximum white blood cell count (1,000/mm3) 20.0 ± 2.0 15.8 ± 1.4 17.5 ± 0.8 16.7 ± 1.9 15.9 ± 0.5
Medical conditions
 Corticosteroid use 1.16
(0.52, 2.61)
0.68
(0.35, 1.33)
2.61
(1.78, 3.84)
7.00
(3.55, 13.82)
1.52
(1.11, 2.12)
 Solid organ allograft 0.93
(0.35, 2.44)
0.67
(0.31, 1.45)
3.13
(2.08, 4.72)
7.20
(3.70, 14.01)
1.25
(0.86, 1.81)
  Liver 0.94
(0.32, 2.74)
0.76
(0.34, 1.72)
3.47
(2.24, 5.39)
6.94
(3.55, 13.53)
1.28
(0.86, 1.93)
  Kidney 0.94
(0.12, 7.16)
0.44
(0.058, 3.29)
0.98
(0.36, 2.68)
1.72
(0.39, 7.62)
1.10
(0.51, 2.45)
  Kidney/pancreas 1.41
(0.27, 7.36)
3.00
(0.35, 25.51)
2.17
(0.66, 7.18)
 Diabetes mellitus 0.44
(0.15, 1.26)
1.34
(0.79, 2.29)
1.46
(0.98, 2.19)
0.28
(0.089, 0.93)
0.96
(0.68, 1.35)
 Cardiac disease 1.05
(0.43, 2.60)
0.36
(0.15, 0.94)
0.84
(0.52, 1.37)
0.58
(0.20, 1.67)
1.35
(0.95, 1.93)
 Malignant disease 0.78
(0.27, 2.25)
1.05
(0.54, 2.07)
1.13
(0.69, 1.86)
0.33
(0.077, 1.37)
0.85
(0.56, 1.30)
 Baseline pulmonary disease 2.67
(1.12, 6.37)
1.48
(0.70, 3.12)
1.06
(0.58, 1.94)
1.94
(0.78, 4.83)
1.77
(1.15, 2.74)
 Ventilator dependence 2.23
(0.83, 6.00)
2.33
(1.15, 4.72)
2.61
(1.49, 4.58)
4.01
(1.80, 8.92)
1.95
(1.23, 3.10)
 Liver disease 1.20
(0.35, 4.05)
1.77
(0.83, 3.76)
2.51
(1.45, 4.34)
5.02
(2.36, 10.68)
1.38
(0.84, 2.27)
 Dialysis dependence 3.03
(1.19, 7.69)
1.06
(0.41, 2.77)
4.37
(2.46, 7.78)
3.78
(1.64, 8.72)
1.05
(0.60, 1.87)
 Crohn's disease/UC 1.43
(0.62, 3.28)
0.22
(0.07, 0.70)
0.74
(0.17, 3.16)
1.27
(0.68, 1.99)
Source of infection
 Stomach 0.88
(0.20, 3.84)
1.25
(0.49, 3.23)
1.71
(0.39, 7.61)
2.16
(1.12, 4.17)
 Duodenum 2.72
(0.60, 12.40)
0.62
(0.080, 4.73)
2.82
(1.03, 7.69)
1.18
(0.15, 9.19)
4.03
(2.06, 7.90)
 Pancreas 0.43
(0.058, 3.22)
2.29
(1.10, 4.77)
2.73
(1.49, 4.99)
1.68
(0.57, 4.93)
0.57
(0.28, 1.15)
 Liver/biliary 1.44
(0.69, 3.01)
1.09
(0.62, 1.89)
1.83
(1.25, 2.67)
2.70
(1.41, 4.19)
0.97
(0.70, 1.36)
 Small bowel 0.29
(0.067, 1.23)
1.12
(0.60, 2.07)
1.17
(0.74, 1.84)
0.55
(0.19, 1.57)
1.45
(1.02, 2.05)
 Appendix 1.32
(0.45, 3.89)
0.11
(0.03, 0.44)
0.27
(0.037, 2.01)
0.12
(0.04, 0.38)
 Colorectal 1.07
(0.50, 2.26)
0.99
(0.58, 1.69)
0.46
(0.29, 0.73)
0.39
(0.15, 1.02)
1.02
(0.74, 1.40)
 Other/unknown 1.36
(0.51, 3.62)
0.99
(0.46, 2.14)
0.74
(0.40, 1.35)
0.94
(0.32, 2.71)
0.52
(0.30, 0.91)
Outcomes
 Duration of antibiotic therapy 14.9 ± 1.3 14.8 ± 0.9 15.5 ± 0.8 18.2 ± 1.6 18.1 ± 1.6
 Length of stay
(days)7
25.7 ± 6.3 24.8 ± 3.5 21.5 ± 1.7 23.9 ± 3.2 23.8 ± 1.8
 In-hospital death 1.78
(0.67, 4.76)
1.29
(0.59, 2.83)
1.62
(0.94, 2.80)
3.68
(1.71, 7.93)
1.88
(1.23, 2.89)

Shaded boxes indicate p < 0.05 by Student's t-test or 95% confidence does not cross 1 compared to infections with no resistant organisms (see Table 3), except for values for all enterococcal infections, which are compared with all infections without resistant pathogens or Enterococcus spp.

1

Includes P. aeruginosa, S. maltophilia, and Acinetobacter spp.

2

Includes methicillin-resistant S. aureus and coagulase-negative staphylococci.

3

Includes vancomycin-resistant and -resistant strains.

4

Vancomycin-resistant enterococci; all were E. faecium.

5

Includes all Candida spp., non-speciated yeast, Aspergillus spp., and other fungi.

6

At time of diagnosis of intra-abdominal infection.

7

From initiation of therapy for intra-abdominal infection.

UC = ulcerative colitis.